Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allen Li

Showing results (261-270 of 270) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 270 results.
Practical Radiation Oncology|December 3, 2019
Patterns of Failure Observed in the 2-Step Institution Credentialing Process for NRG Oncology/Radiation Therapy Oncology Group 1005 (NCT01349322) and Lessons LearnedX Allen Li, Jennifer Moughan, Julia R White, et al.
Molecular Psychiatry|August 9, 2024
Deletion of murine astrocytic vesicular nucleotide transporter increases anxiety and depressive-like behavior and attenuates motivation for rewardQian Huang, Hiu Ham Lee, Bryan Volpe, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2019
The transformation of radiation oncology using real-time magnetic resonance guidance: A reviewWilliam A Hall, Eric S Paulson, Uulke A van der Heide, et al.
British Journal of Haematology|June 25, 2025
Iron overload and morbidities in Chinese with non-transfusion-dependent thalassaemiaWing-Yan Leung, Tracy Yuen-Han Lee, Yu-Yan Hwang, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
(R)-2-Phenylpyrrolidine Substituted Imidazopyridazines: A New Class of Potent and Selective Pan-TRK InhibitorsHa-Soon Choi, Paul V Rucker, Zhicheng Wang, et al.
NPJ Precision Oncology|October 20, 2021
Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapiesMarilyne Labrie, Allen Li, Allison Creason, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2026
Concurrent Versus Sequential Radiation Dose Escalation to the Surgical Cavity for Conservative Treatment of High-Risk Early Breast Cancer: NRG/RTOG 1005 Phase III TrialFrank A Vicini, Kathryn Winter, Gary M Freedman, et al.
The New England Journal of Medicine|June 4, 2025
Omitting Regional Nodal Irradiation after Response to Neoadjuvant ChemotherapyEleftherios P Mamounas, Hanna Bandos, Julia R White, et al.
Nature|June 16, 2012
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinomaPedro A Pérez-Mancera, Alistair G Rust, Louise van der Weyden, et al.
Clinical and Translational Radiation Oncology|November 3, 2018
Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trialHouda Bahig, Ying Yuan, Abdallah S R Mohamed, et al.
Pageof 27

Showing results (261-270 of 270) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 270 results.
Practical Radiation Oncology|December 3, 2019
Patterns of Failure Observed in the 2-Step Institution Credentialing Process for NRG Oncology/Radiation Therapy Oncology Group 1005 (NCT01349322) and Lessons LearnedX Allen Li, Jennifer Moughan, Julia R White, et al.
Molecular Psychiatry|August 9, 2024
Deletion of murine astrocytic vesicular nucleotide transporter increases anxiety and depressive-like behavior and attenuates motivation for rewardQian Huang, Hiu Ham Lee, Bryan Volpe, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2019
The transformation of radiation oncology using real-time magnetic resonance guidance: A reviewWilliam A Hall, Eric S Paulson, Uulke A van der Heide, et al.
British Journal of Haematology|June 25, 2025
Iron overload and morbidities in Chinese with non-transfusion-dependent thalassaemiaWing-Yan Leung, Tracy Yuen-Han Lee, Yu-Yan Hwang, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
(R)-2-Phenylpyrrolidine Substituted Imidazopyridazines: A New Class of Potent and Selective Pan-TRK InhibitorsHa-Soon Choi, Paul V Rucker, Zhicheng Wang, et al.
NPJ Precision Oncology|October 20, 2021
Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapiesMarilyne Labrie, Allen Li, Allison Creason, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2026
Concurrent Versus Sequential Radiation Dose Escalation to the Surgical Cavity for Conservative Treatment of High-Risk Early Breast Cancer: NRG/RTOG 1005 Phase III TrialFrank A Vicini, Kathryn Winter, Gary M Freedman, et al.
The New England Journal of Medicine|June 4, 2025
Omitting Regional Nodal Irradiation after Response to Neoadjuvant ChemotherapyEleftherios P Mamounas, Hanna Bandos, Julia R White, et al.
Nature|June 16, 2012
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinomaPedro A Pérez-Mancera, Alistair G Rust, Louise van der Weyden, et al.
Clinical and Translational Radiation Oncology|November 3, 2018
Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trialHouda Bahig, Ying Yuan, Abdallah S R Mohamed, et al.
Pageof 27